This leads to thinning of aortic wall and smooth muscle cell (SMC) release of matrix degrading enzymes, such as matrix metalloproteinase 2 (MMP2), which mediates aortic aneurysm pathogenesis (11, 12). This evidence concerns the gene MMP2 and aortic aneurysm.